Related references
Note: Only part of the references are listed.Pregnancy outcomes in women with inflammatory bowel disease: A large community-based study from Northern California
Uma Mahadevan et al.
GASTROENTEROLOGY (2007)
Therapeutic drug use in women with crohn's disease and birth outcomes:: A danish nationwide cohort study
Bente Norgard et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations
R Caprilli et al.
GUT (2006)
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission:: A predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials
WJ Sandborn et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial
S Hanauer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial
JC Escher
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Pharmacokinetics of budesonide (Entocort (TM) EC) capsules for Crohn's disease
S Edsbacker et al.
CLINICAL PHARMACOKINETICS (2004)
Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonide
E Norjavaara et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Inflammatory bowel disease in pregnancy
S Kane
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2003)
Share Paper
